ClinicalTrials.gg
Enrolling by invitationNCT03506867HPIUpdated Dec 24, 2025

Healthy People Initiative (HPI)

An interventional study of Life skills, training, education and work/volunteer opportunities and Usual Care in Nicotine Dependence and Substance Use Disorders, sponsored by Ottawa Hospital Research Institute. Enrolling by invitation at 1 site in Canada. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-24.

Sponsored by Ottawa Hospital Research Institute · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 43 studies in Tobacco Use Disorder with a site in Canada — 10 open to participants now, 10 under way, 1 of them phase 3. Tobacco Use Disorder · Canada.

Planned enrollment
9th of 41
250 · median 43
Started
2019
with 1 other
No phase
19 of 43
4 open now
Registered
31st of 43
by date
Lead sponsor
2 of 43
Ottawa Hospital Research Institute

Among the 43 studies in Tobacco Use Disorder with a site in Canada, this one is the 9th largest by planned enrollment of the 41 interventional ones that give a count, is one of 2 that started in 2019, is one of 19 with no phase, and was the 31st registered.

Tobacco Use Disorder

1,028 studies on the registry are indexed under Tobacco Use Disorder; 128 are open to participants now.

Browse Tobacco Use Disorder studies →

Open to participants now

10 of the 43 studies in Tobacco Use Disorder with a site in Canada are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 95 Tobacco Use Disorder studies recruiting now, 42 (44%) set no upper age limit and 50 (53%) stop at 75 or younger; 6 take children under 18; 37 take healthy volunteers.

This study: 16 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 43 studies in Tobacco Use Disorder with a site in Canada, or all of them as a file.
02

Study summary

Addictions do not occur in isolation. Tackling addictions requires addressing social determinants such as isolation, homelessness, marginalization, and unemployment. Research on individuals living with or at risk for HIV/AIDS highlights that unemployment correlates with higher levels of depression, anxiety, and social isolation compared to employment. In Ottawa, the PROMPT project engaged homeless or at-risk populations, including people who use drugs and those living with or at risk for HIV/AIDS or Hepatitis C using the Bridge ModelTM, a pragmatic community-based participatory action research approach operationalized through earlier projects at the Bridge Engagement Center in Ottawa, Canada. The PROMPT project demonstrated that implementing multi-component, complex interventions is both feasible and effective, achieving broader socio-economic outcomes beyond reduction and quitting tobacco and poly-substance use. However, PROMPT participants identified a lack of social and recovery capital -family and social connections, opportunities for volunteering and jobs- as a major barrier to recovery. To address this, we conducted a six-month feasibility pilot study with 20 PROMPT participants. By its conclusion, 15 participants were engaged in small paid or volunteer roles, including educational opportunities, fostering both social integration and recovery. Insights from this pilot study informed the design of a larger community-based multi-site pragmatic randomized trial (RCT) to further evaluate the effectiveness of the Bridge ModelTM, the Healthy People Initiative (HPI) project. The Healthy People Initiative (HPI) is a community-based, participatory, pragmatic parallel-arm multi-site with a cross-over design, recruiting 250 participants (16+) at risk of homelessness or low socioeconomic status in Ottawa and Toronto, Canada.

Read the detailed description

Title of Trial: A Healthy People Initiative (HPI) - Community-Based Participatory Action Pragmatic Parallel Arm Multi-Site Randomized Controlled Trial using The Bridge ModelTM in Systemically Disadvantaged Populations: HPI Trial Protocol

Short Title of Trial: HPI Trial

Principal Investigator: Smita Pakhalé

Trial Sites: Ottawa (The Bridge Engagement Centre) \& Toronto (Parkdale Activity Recreation Centre)

Primary outcome: The Healthy People Initiative (HPI) randomized controlled trial (RCT) builds on the pilot study to evaluate changes in participants' self-reported quality of life (QoL) as the primary outcome while implementing the Bridge Model™ approach to address tobacco management.

Secondary outcomes: The secondary objective is to quantify reductions in tobacco use and quitting tobacco use altogether, with quit rates validated biochemically, and changes in self-efficacy.

Tertiary outcomes: These include evaluating process-related metrics such as participant enrolment rates, consent rates, and adherence to protocol; estimating implementation costs to guide future cost-effectiveness analyses; and assessing additional patient-reported outcomes such as self-efficacy, participation in education or employment, and reductions in polysubstance use. Additionally, a cost-utility analysis from a health system perspective will assess the economic impact of the 52-week intervention by measuring total costs and healthcare utilization, linking trial data to administrative health records. We aim to provide robust evidence to support the utility of the Bridge ModelTM in addressing health and social inequities through community-driven, peer-led interventions that integrate social determinants with individual health outcomes.

Primary Objective: To assess the feasibility of a randomized controlled trial investigating access to improvements in 'social capital' in the low income population in Ottawa and Toronto.

Study Design \& Population: The HPI study is a crossover, community-based, multi-site pragmatic RCT (1:1 allocation ratio) in Ottawa and Toronto. It uses a 12-month follow-up to evaluate short- and long-term effects of the intervention on health, social, and economic outcomes. Data sources include self-reports, biochemical validation, and administrative health records

Sample Size: 250

Trial Arms: The HPI RCT has two arms: usual care and intervention (Figure 1). The intervention arm employs the Bridge ModelTM, offering life-skills workshops, social integration, peer guidance, system navigation (e.g., housing), and APN (Advanced Practice Nurse) or NP (Nurse Practitioner) counselling, including primary care, preventive services, and referrals. Both arms receive monthly follow-ups from peers and APN/NP. Usual care includes resource information and counselling, with an option to switch to the intervention arm after six months. All participants receive nicotine replacement therapy (NRT) for 12 months as needed.

Trial Duration: 12 months Follow-up Duration: 12 months

03

Conditions studied

  • Nicotine Dependence
  • Substance Use Disorders

Keywords

  • Health Equity
  • Community Based Participatory Action Research
  • Poverty Reduction
04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must be 16 years or older, reside in Ottawa or Toronto,
  • Have smoked tobacco in the past 7 days
  • Identify as low socioeconomic status and/or at risk of homelessness, and be available for in-person follow-up for one year.

Exclusion criteria

Exclusion criteria:

  • Declining consent
  • Any person who is in or planning on accessing addictions treatment (in-patient drug rehabilitation) in Ottawa or Toronto and hence will be unavailable for follow up
  • Currently or recently (in the past 30 days) enrolled in any other smoking cessation program
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
250 participants (estimated)

Study arms

  • Active comparator
    Usual care arm

    We will provide the participants in this arm with pamphlets and knowledge about available services in the city through partner agencies.

    Behavioral: Life skills, training, education and work/volunteer opportunities

  • Active comparator
    Life skills, training, education and work/volunteer opportunities, and peer support

    The life skills, training, education, work/volunteer opportunities, and peer support arm will be offered to the usual care arm participants after the first six months of study enrollment.

    Behavioral: Usual Care

Interventions

  • BehavioralLife skills, training, education and work/volunteer opportunities

    Intervention arm will receive proactive and sustained access to enhanced education and socio-economic supports (e.g. volunteer and/or work opportunities).

  • BehavioralUsual Care

    We will provide the participants in this arm with pamphlets and knowledge about available services in the city through partner agencies.

06

What researchers measure

Primary outcomes

  1. Self-Reported Quality of Life

    To assess the trend in self-reported quality of life using the European Quality of Life 5 Dimensions 5 Level Version.

    Time frame: 12 Months

Secondary outcomes

  1. Self-Reported Efficacy

    To estimate change in self-reported self-efficacy.

    Time frame: 12 months

  2. Tobacco use

    To estimate self-reported reduced or quit tobacco use rate (corroborated with the measurement of exhaled Carbon Monoxide) and poly-substance use rate.

    Time frame: 12 months

Other outcomes

  1. Consent and Protocol Violation Rate

    The consent rate of eligible participants and the rate of protocol violations resulting in cross contamination of the groups receiving study intervention

    Time frame: 12 months

  2. Healthcare Utilization Rate

    To compare healthcare utilization (ER visits and hospitalizations) over one year before and after the study by linking the trial data to health administrative data available at the Institute for Clinical and Evaluative Sciences (ICES).

    Time frame: 12 months

  3. Access to Work, Training, and Volunteer Opportunities

    To assess access to work, training, or volunteering positions using a self-reported online survey.

    Time frame: 12 months

  4. Costs of Poverty Reduction Intervention

    To estimate the costs of poverty reduction intervention (life skills workshops, training, and education/volunteer/employment opportunities.

    Time frame: 12 months

  5. Average Recruitment Rate

    To assess the ability of participating sites to enroll an average of 6 participants per month.

    Time frame: 12 months

  6. Poly-substance use rates

    Reductions in polysubstance use (biochemically validated)

    Time frame: 12 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Upon request study de-identified data will be made available to interested and qualified researchers.

Time frame: Upon request study de-identified data will be made available to interested and qualified researchers. No time frame necessary.

Access criteria: No access criteria. De-identified raw data will be available upon request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2019 (actual). Primary completion is estimated for Mar 2027, 98 months after the start.

Of 257 non-industry interventional studies with no phase under Tobacco Use Disorder, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 51. This study's planned 98 months is above that.

Counting every sponsor, half of 267 studies reached it within 32 months; a quarter within 16 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 29, 2018
First posted
Apr 24, 2018
StartActual
Jan 3, 2019
Primary completionEst.
Mar 31, 2027
CompletionEst.
Mar 31, 2027
Last update
Dec 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03506867
Responsible party
Sponsor
First posted
Apr 24, 2018
Start date
Jan 3, 2019
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Dec 24, 2025

Study contacts

Smita Pakhalé, MD, MSc
principal investigator · The Ottawa Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion